Antimicrobial Resistance Surveillance Market Share

Statistics for the 2023 & 2024 Antimicrobial Resistance Surveillance market share, created by Mordor Intelligence™ Industry Reports. Antimicrobial Resistance Surveillance share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Antimicrobial Resistance Surveillance Industry

The antimicrobial resistance surveillance market is moderately consolidated and competitive due to the presence of many players. The market's major players are concentrating on joint ventures, strategic alliances, introducing new products, and geographic growth into developing and economically advantageous areas. Some of the major players include Thermo Fisher Scientific, Pfizer Inc., Cepheid, Accelerate Diagnostics, In, Liofilchem S.r.l., Becton Dickinson and Company, Biomerieux, Bruker, Merck KgaA, Bio-Rad Laboratories, Inc., Qiagen, SyntBioLab INC, Sysmex Inostics, Guardant Health, Inc, Exact Sciences Corporation.

Antimicrobial Resistance Surveillance Market Leaders

  1. Pfizer Inc.

  2. Merck KgaA

  3. Thermo Fisher Scientific

  4. Cepheid

  5. Liofilchem S.r.l.

*Disclaimer: Major Players sorted in no particular order

Antimicrobial Resistance Surveillance Market Concentration

Antimicrobial Resistance Surveillance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)